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activity brief

Modeling the Expected Cost-effectiveness and
Impact of Oral Pre-exposure Prophylaxis in
Uganda and Swaziland

Prior modeling work has demonstrated that oral
PrEP is most cost effective when targeted to
populations at very high risk of infection, with
risk dependent on a combination of individual
behavior and epidemic contexts. Project SOAR is
assisting Uganda and Swazilandi in making critical
decisions about oral PrEP introduction and scale
up by modelling the expected cost-effectiveness
PrEP modelling is also being conducted in Mozambique and Lesotho
through Health Policy Plus (HP+).
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Clinical trials have shown that oral antiretrovirals
(ARVs) containing tenofovir/emtricitabine used by
HIV-negative individuals to prevent HIV acquisition,
called oral pre-exposure prophylaxis (PrEP), are
safe and effective in several populations. Oral
PrEP is now considered part of the PEPFAR HIV
prevention toolkit, and procurement by PEPFAR
is permitted in countries where (1) test and start
policies have been initiated; (2) viral load testing
policies call for testing at least annually; and (3)
multi-month ARV provision is available for stable
clients.

Modelling the expected cost effectiveness and impact
of oral PrEP within Uganda and Swaziland’s portfolio
of HIV interventions will help each country make
critical decisions about oral PrEP.

and impact of oral PrEP within each country’s
larger portfolio of HIV prevention interventions.

i

Research Partners: Avenir Health,
Palladium

Location: Swaziland and Uganda
Study Duration: 2017–2018
For more information, contact Steven
Forsythe, Avenir Health, sforsythe@
avenirhealth.org.

OUR RESEARCH

The Project SOAR team first worked with country
stakeholders to identify specific modeling
questions that would be helpful to advance
PrEP policy and implementation planning and
discussions in-country (see box on next page
for Uganda’s questions). SOAR then adapted,
expanded, and applied existing modeling tools
to estimate the expected cost-effectiveness and
impact of oral PrEP within the larger portfolio of
HIV prevention interventions. The modeling tools
used are the Goals Model and the Incidence
Patterns Model (IPM), which uses published
data in Demographic and Health Surveys (DHS),

What would Uganda like to know from
PrEP modelling?
 How would rolling out oral PrEP to different
risk groups and geographic areas affect the
impact, cost-effectiveness, and total cost of
oral PrEP?
 How do the impact, cost, and cost
effectiveness vary by risk group?
 Female sex workers
 Serodiscordant couples
 Men who have sex with men
 People who inject drugs
 Adolescent girls and young women with
multiple partners
 How would varying levels of future scaleup of ART and voluntary medical male
circumcision affect the impact and costeffectiveness of oral PrEP?
 How would varying unit costs of oral PrEP
by risk group affect the relative costeffectiveness of providing PrEP to the
different risk groups?
 How would varying levels of adherence by
risk group affect the relative impact and
cost-effectiveness of providing PrEP to the
different risk groups?

Population-based HIV Impact Assessments (PHIA)
and AIDS Indicator Surveys (AIS) to estimate HIV
incidence in each risk group and province. These
two models are then combined into a single
platform to create the Oral PrEP Workbook—a
Microsoft Excel-based tool that links the IPM with
Goals and visualizes the results to address policy
questions raised in each country.

Project SOAR is a five-year (September 2014–September 2019) cooperative
agreement funded by the President’s Emergency Plan for AIDS Relief
and the U. S. Agency for International Development (Agreement No. AIDOAA-A-14-00060). SOAR is able to accept funding from all USAID accounts.
Population Council leads the Project SOAR consortium in collaboration with
Avenir Health, Elizabeth Glaser Pediatric AIDS Foundation, the Johns Hopkins
University, Palladium, and The University of North Carolina at Chapel Hill.

Strengths of our modelling approach
 Combines the more detailed risk structure
of IPM with the dynamic projections and HIV
interventions in the Goals Model.
 Incorporates risk groups not previously
modeled in Goals: serodiscordant couples,
adolescent girls and young women.
 Dynamic modeling can take into account
projected changes in HIV incidence from
scaling up ART and other HIV prevention
interventions.
 Use of rigorous data from published DHS,
PHIA and AIS surveys to disaggregate HIV
incidence by risk group.
 Oral PrEP Workbook allows users flexibility in
defining rates and levels of scale-up of PrEP,
target populations, unit costs, etc. while
automating the communication between the
IPM and Goals Model.

RESEARCH UTILIZATION

SOAR, in consultation with the USAID Missions,
is presenting their analytical findings in-country
to stakeholders within the Ministries of Health
and National AIDS Control Programs in Swaziland
and Uganda. The purpose of these meetings is to
discuss the implications of PrEP in each country
and design a strategy for moving forward.
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